{"id":"https://openalex.org/W4410805259","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590","title":"A single-center, prospective, randomized controlled trial of tislelizumab combined with platinum-containing chemotherapy as first-line treatment for HIV-positive patients with advanced non-small cell lung cancer.","display_name":"A single-center, prospective, randomized controlled trial of tislelizumab combined with platinum-containing chemotherapy as first-line treatment for HIV-positive patients with advanced non-small cell lung cancer.","publication_year":2025,"publication_date":"2025-05-28","ids":{"openalex":"https://openalex.org/W4410805259","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.16_suppl.e20590","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042274048","display_name":"Yaping Quan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yaping Quan","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051571832","display_name":"Hao Li","orcid":"https://orcid.org/0009-0005-4886-9666","observed_orcids":["https://orcid.org/0009-0005-4886-9666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao Li","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xianhuai Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xianhuai Jin","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101945805","display_name":"Yan Zeng","orcid":"https://orcid.org/0000-0001-9413-6141","observed_orcids":["https://orcid.org/0000-0001-9413-6141","https://orcid.org/0009-0007-0299-6664","https://orcid.org/0000-0003-3802-9119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Zeng","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011088053","display_name":"Jie Shen","orcid":"https://orcid.org/0000-0002-6021-7151","observed_orcids":["https://orcid.org/0000-0002-6021-7151"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Shen","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yongwei Duan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yongwei Duan","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039255086","display_name":"Nan Lin","orcid":"https://orcid.org/0000-0002-4635-3966","observed_orcids":["https://orcid.org/0000-0002-4635-3966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nan Lin","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103070086","display_name":"Yong Hu","orcid":"https://orcid.org/0000-0002-4345-1640","observed_orcids":["https://orcid.org/0000-0002-4345-1640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Hu","raw_affiliation_strings":["The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Department of Oncology, Guiyang Public Health Clinical Center, Guiyang, China","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.12831019,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"16_suppl","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.12399999797344208,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.09480000287294388,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tislelizumab","display_name":"tislelizumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.718999981880188},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5320000052452087},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7390000224113464},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.8009999990463257},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.7829999923706055},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.5040000081062317},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.5690000057220459},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6489999890327454},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.984000027179718},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.7670000195503235},{"id":"https://openalex.org/keywords/people-living-with-hiv","display_name":"people living with HIV","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9136968851089478},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6514395475387573},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5985475778579712},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.579987108707428},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5232464671134949},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4437626004219055},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44041168689727783},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4356546103954315},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4210614562034607},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3288213014602661},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.1421513855457306}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.16_suppl.e20590","doi":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.e20590","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2355769538","https://openalex.org/W2081816252","https://openalex.org/W2015216653","https://openalex.org/W2373885168","https://openalex.org/W2112436308","https://openalex.org/W2362391294","https://openalex.org/W3139914494","https://openalex.org/W2914553161","https://openalex.org/W1556819926","https://openalex.org/W3179965273"],"abstract_inverted_index":{"e20590":[0],"Background:":[1],"There":[2],"are":[3,275],"few":[4],"prospective":[5],"clinical":[6,41],"studies":[7],"of":[8,19,183,245,252,267,288],"programmed":[9],"death-1":[10],"(PD-1)":[11],"inhibitors":[12],"combined":[13,74,83,254],"with":[14,25,75,84,95,133,138,255,260],"chemotherapy":[15,77,256],"in":[16,116,164,171,178,225,234],"the":[17,128,243,286],"treatment":[18],"human":[20],"immunodeficiency":[21],"virus":[22],"(HIV)-infected":[23],"patients":[24,54,71,113,259,274],"advanced":[26,261,269],"non-small":[27],"cell":[28],"lung":[29],"cancer":[30],"(NSCLC)":[31],"since":[32],"this":[33],"population":[34],"has":[35],"largely":[36],"been":[37],"excluded":[38],"from":[39],"immunotherapy":[40],"trials.":[42],"Methods:":[43],"The":[44,152,248,290],"single-center,":[45],"prospective,":[46],"randomized":[47],"controlled":[48],"trial":[49],"enrolled":[50,115],"stage":[51],"IIIC-IV":[52],"NSCLC":[53,262,270],"and":[55,60,107,111,119,161,213,228,250,281,294],"divided":[56],"them":[57],"into":[58],"HIV-positive":[59,117,134,159,172,226,235,258,273],"HIV-negative":[61,120,139,165,179,229],"groups":[62,130],"based":[63],"on":[64],"whether":[65],"they":[66],"had":[67,237],"HIV":[68],"infection.":[69],"All":[70],"received":[72],"tislelizumab":[73,96,253],"platinum-containing":[76],"(paclitaxel":[78],"or":[79,81,86,100,216],"nab-paclitaxel":[80],"pemetrexed":[82],"cisplatin":[85],"carboplatin)":[87],"for":[88,257],"4-6":[89],"cycles,":[90],"followed":[91],"by":[92],"maintenance":[93],"therapy":[94],"until":[97],"disease":[98],"progression":[99,195],"intolerable":[101],"toxicities.":[102],"Results:":[103],"Between":[104],"January":[105],"2023":[106],"December":[108],"2024,":[109],"17":[110],"37":[112],"were":[114,125,211,221],"group":[118,135,160,173,227,236],"group,":[121,230],"respectively.":[122,231],"Baseline":[123],"characteristics":[124],"balanced":[126],"between":[127],"two":[129],"(male,":[131],"82.4%":[132,201],"vs":[136,144,150,176,189,202,223],"89.4%":[137],"group;":[140],"median":[141,153],"age,":[142],"61":[143],"59":[145],"yrs;":[146],"squamous":[147],"carcinoma,":[148],"76.5%":[149,175],"72.3%).":[151],"follow-up":[154],"was":[155,174,187,200],"7.3":[156],"months":[157],"(range,2.5-24m)in":[158],"13.4":[162],"months(range,1.8-24m)":[163],"group.":[166],"Objective":[167],"response":[168,184],"rates":[169],"(ORR)":[170],"78.3%":[177],"group(p=0.746);":[180],"6-month":[181,194],"duration":[182],"(DOR)":[185],"rate":[186,199],"70.6%":[188],"78.3%(HR":[190],"1.110,95%":[191],"CI":[192,205],"0.782-1.576,p=0.078);":[193],"free":[196],"survival":[197],"(PFS)":[198],"94.6%(HR":[203],"1.149,95%":[204],"0.910-1.450,p=0.876).":[206],"No":[207],"new":[208],"safety":[209,251],"signals":[210],"observed,":[212],"grade":[214],"3":[215],"higher":[217],"immune-related":[218],"adverse":[219],"reactions":[220],"5.9%":[222],"5.4%":[224],"One":[232],"patient":[233],"an":[238],"opportunistic":[239,279],"infection-induced":[240],"death":[241],"during":[242],"course":[244,287],"treatment.":[246,289],"Conclusions:":[247],"efficacy":[249],"is":[263,292],"comparable":[264],"to":[265,278],"that":[266],"non-HIV":[268],"patients.":[271],"However,":[272],"more":[276],"susceptible":[277],"infections":[280],"require":[282],"closer":[283],"management":[284],"throughout":[285],"study":[291],"ongoing":[293],"requires":[295],"further":[296],"follow-up.":[297]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}